Cargando…
Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies
The introduction of direct-acting antivirals (DAAs) has revolutionized hepatitis C treatment. Short courses of treatment with these drugs are highly beneficial to patients, eliminating hepatitis C virus (HCV) without adverse effects. However, this outstanding success is tempered by the continuing di...
Autores principales: | Gomez-Escobar, Elsa, Roingeard, Philippe, Beaumont, Elodie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220683/ https://www.ncbi.nlm.nih.gov/pubmed/37243237 http://dx.doi.org/10.3390/v15051151 |
Ejemplares similares
-
Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties
por: Beaumont, Elodie, et al.
Publicado: (2016) -
Incorporation of apolipoprotein E into HBV–HCV subviral envelope particles to improve the hepatitis vaccine strategy
por: Gomez-Escobar, Elsa, et al.
Publicado: (2021) -
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
por: Sliepen, Kwinten, et al.
Publicado: (2022) -
Sequential biogenesis of host cell membrane rearrangements induced by hepatitis C virus infection
por: Ferraris, Pauline, et al.
Publicado: (2012) -
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate
por: Wang, Ruixue, et al.
Publicado: (2022)